Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

Press releases published on October 19, 2026

Oct. 19, 2026

Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Indeterminate GlobeNewswire

Oct. 19, 2026

Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences

Indeterminate GlobeNewswire

Oct. 19, 2026

ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Syncromune to Present Updated Long-Term Overall Survival Data from Phase 1 Trial of SYNC-T Therapy SV-102 in Metastatic Prostate Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®

Indeterminate GlobeNewswire

Oct. 19, 2026

Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting

Indeterminate GlobeNewswire

Oct. 19, 2026

Medera's Novoheart Technology Powers Advanced Human Cardiac Disease Modeling at Singapore's New CIPHER Research Centre

Indeterminate GlobeNewswire

Oct. 19, 2026

Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Hyperion DeFi Schedules Third Quarter Earnings Call for Thursday, November 12 at 8:00 a.m. ET

Indeterminate GlobeNewswire

Oct. 19, 2026

Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.

Indeterminate GlobeNewswire

Oct. 19, 2026

Six Studies to Highlight Veracyte’s Genomic Tests Across Breast, Prostate and Bladder Cancer at ESMO 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING

Indeterminate GlobeNewswire

Oct. 19, 2026

Ritedose Partners with Newberry College to Launch Leadership Development Program

Indeterminate GlobeNewswire

Oct. 19, 2026

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week

Indeterminate GlobeNewswire

Oct. 19, 2026

Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases

Indeterminate GlobeNewswire

Oct. 19, 2026

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire